Unaudited Financial Result for quarter ended 30th June 2026

Registered Office: KANORIACHEMICALS & INDUSTRIES UMITED KCI Plaza, 6th Floor 23C, Ashutosh Chowdhury Avenue Kolkata-700 019 Tel: +9 I-33-403 I-3200 CIN :L2411OWB1960PLC024910 E-mail: calall@kanoriachem.com Website:www.kanoriachem.com Date: 11thAugust 2026 To, To, The Manager, The Secretary, Listing Department BSELimited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street, Mumbai - 400 001 Bandra Kurla Complex, Script Code: 506525 Bandra (E), Mumbai - 400 051 Symbol: KANORICHEM Dear Sir, SYJl: Outcome of the Board Meeting This isto inform that the Board of Directors of the Company at its Meeting held today i.e., 11th August, 2026, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30thJune, 2026 along with the Limited Review Reports. The meeting commenced at 11:45 a.m. and concluded at Thanking you, Yours sincerely, For Kanoria Chemicals & Industries Limited Pratibha Jaiswal Company Secretary CorporateOffice: IndraPrakash,21,BarakhambaRoad,NewDelhi-110001,Tel: 91-11-4357-9200,Fax: 91-11-2371-7203,2376-6486 Sing/i,i el Co. 161, Sarat Bose Road Kotkata-700 026, (India) T +91(0)33-2419 G<XX)/01/02 Chartered Accountants E kolkata@slnghico.com www.1lnghlco.com limited Review Report on the Quarterly Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The Board of Directors of Kanoria Chemicals & Industries limited 1. We have reviewed the accompanying statement of unaudited standalone financial results together with notes thereon ("the Statement") of M/S. KANORIA CHEMICALS & INDUSTRIES LIMITED ("the Company") for the quarter ended June 30, 2026. The statement is being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended (the Regulation). 2. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors in their meeting held on August 11, 2026, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under section 133, of the Companies Act, 2013 as amended read with relevant rules issued there under and other accounting principles .g enerally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review . 3. We conducted our review of the statement in accordance with the Standard on Review Engagements {SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity," issued by the Institute of Chartered Accountants of India {ICAI). A review of interim financial information consists of making enquiries primarily of persons responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the standards on auditing and consequently does not enable us to obtain assurance that we would be aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement prepared in accordance with applicable Indian Accounting Standards as specified in Section 133 of the Companies Act, 2013, as amended read with the relevant rules issued there under and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. Other Matter 5. The figures for the three months ended March 31, 2026 as reported in these financial results are the balancing figures between audited figures in respect of the full previous financial year and the published year to date figures up to the third quarter of the previous financial year. The figures up to the end of the third quarter of previous financial year had only been reviewed and not subjected to audit. Our conclusion on the statement is not modified in respect of the above matter. For Singhi & Co. Chartered Accountants Firm Registration No. 302049E (Rahul Bothra) Partner Membership No. 067330 UDIN:26067330CJHWUD3301 Place: Kolkata Dated: August 11, 2026 Offices, Kolkata, Deihl NCR, Mumbai, Chennai, Bengaluru, Pune & Raipur KANORIA CHEMICALS&INDUSTRIESLIMITED uKCIPlaza",6th Floor,23C,Ashutosh Chowdhury Avenue, Kolkata-700019 PhoneNo.+913340313200 Website: www.kanoriachem.com CIN:L24110WB1960PLC024910 (INR in Lakhs) STATEMENTOFUNAUDITEDSTANDALONEFINANCIALRESULTSFORTHEQUARTERENDED30THJUNE,2026 Quarter ended Yearended (Unaudited) (Audited) (Unaudited) (Audited) 30.06.2026 31.03.2026 30.06.2025 31.03.2026 INCOME Revenuefrom Operations 42,999 26,734 18,654 87,534 OtherIncome(ReferNoteNo.2) 902 842 770 2,689 Total Income 43,901 27,576 19,424 90,223 EXPENSES Costof Materials Consumed 21,910 14,144 12,724 55,297 PurchaseofStock-in-Trade 14,153 6,081 605 10,132 ChangeinInventoriesofFinishedGoodsandWork-in-Progress (1,650) 521 319 (146) EmployeeBenefitExpenses 1,202 1,126 1,083 4,473 Other Expenses 3,696 3,195 2,789 12,310 Total Expenses 39,311 25,067 17,520 82,066 Profit before FinanceCosts,Depreciation &Amortisation, Exceptional ItemsandTax 4,590 2,509 1,904 8,157 FinanceCosts(ReferNoteNo.2) 471 525 428 1,945 DepreciationandAmortisation Expenses 594 581 548 2,281 Profit/(Loss) before ExceptionalItemsandTax 3,525 1,403 928 3,931 ExceptionalItem(ReferNoteNo.3) - - 1,064 1,064 Profit/(Loss) before Tax 3,525 1,403 (136) 2,867 TaxExpenses: CurrentTax 567 272 161 732 DeferredTax 321 (1,844) 170 (1,416) Taxfor EarlierYears - 110 - 110 Profit/(Loss) for the period 2,637 2,865 (467) 3,441 OTHERCOMPREHENSIVEINCOME(OCI) A(i)Itemsthat will not bereclassifiedto ProfitorLoss 6 129 2 278 (ii)IncomeTaxrelatingto itemsthat will notbereclassifiedto Profit orLoss - (9) 1 (26) B(i)Itemsthat will bereclassifiedto ProfitorLoss - - - - Other Comprehensive Incomefor the Period(netoftax) 6 120 3 252 Total Comprehensive Incomefor the Period 2,643 2,985 (464) 3,693 PaidupEquityShareCapital(INR5/- perShare) 2,185 2,185 2,185 2,185 OtherEquity - - - 61,631 (not (not (not EarningperShare- (annualised) annualised) annualised} annualised} Basic&Diluted(INR) 6.03 6.56 (l.07) 7.88 Notes: 1The above Unaudited StandaloneFinancialresults have been reviewed by the Audit Committee and approved by the Board of Directors at their respectivemeetingsheldon11thAugust,2026.LimitedReviewoftheseresultshasbeencarriedout bytheStatutoryAuditors oftheCompany. 2Thecompanyhasissued4,95,000Non-Convertible,Non-Cumulative,Non-Participating, Redeemable7%PreferenceShares(NCRPS)of Rs1,000/-each at par,aggregatingto Rs.4,950lakhson April 2026. Inlinewith the requirement ofINDAS-109,"FinancialInstruments," theseNCRPSwerefair valuedusingthe effective interest methodatRs.4,320lakhsresultinginagainof Rs.630lakhswhichisincludedinOtherIncome.Simultaneously,the FinanceCostincludes anotional interest of Rs.8 lakhsbeing the amortised portion of this gain pertaining to the quarter ended 30th June,2026. DeferredTaxincludesRs.156lakhsbeingthedeferredtaxliability arisenfrom theseadjustments. 3 ExceptionalItem includesthe impairment inthevalueofthe Company'sinvestment inEquitysharesofAPAGHoldingAGbyRs.1,064lakhsduringthe quarter ended30thJune,2025&yearended31stMarch,2026. 4 The Company is primarily engagedin the businessof manufacturing of Chemicalswhich isconsidered asone reportable segment and hence,no additional disclosureswith respecttosegmentinformation havebe [Showing first 8,000 characters — download PDF for full document]